The Next Vaccine Debate: Immunize Young Children Now, or Wait?news2022-02-09T20:16:21+00:00February 9th, 2022|The New York Times|
Alzheimer’s Drug Aduhelm Faces Crucial Medicare Decisionnews2021-12-31T21:39:22+00:00December 31st, 2021|The New York Times|
F.D.A. Clears Pfizer’s Covid Pill for High-Risk Patients 12 and Oldernews2021-12-22T22:02:31+00:00December 22nd, 2021|The New York Times|
Biogen Slashes Price of Alzheimer’s Drug Aduhelm, as It Faces Obstaclesnews2021-12-21T02:08:14+00:00December 21st, 2021|The New York Times|
Pfizer’s Covid Pill Works Well, Company Confirms in Final Analysisnews2021-12-15T02:22:07+00:00December 15th, 2021|The New York Times|
Merck’s Covid Pill Might Pose Risks for Pregnant Womennews2021-12-13T15:27:03+00:00December 13th, 2021|The New York Times|
Los nuevos antivirales para la covid ofrecen esperanza frente a la variante ómicronnews2021-12-08T15:49:42+00:00December 8th, 2021|The New York Times|
New Covid Antiviral Pills Offer Hope as Omicron Loomsnews2021-12-07T08:00:09+00:00December 7th, 2021|The New York Times|
South African Company Nears License to Sell J. & J. Covid Shot Across Africanews2021-11-30T21:07:51+00:00November 30th, 2021|The New York Times|
¿Las vacunas funcionan para la variante ómicron?news2021-11-29T23:50:30+00:00November 29th, 2021|The New York Times|
